U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143227) titled 'A Study of XW003 Injection in Chinese Adolescents With Obesity' on Aug. 13.
Brief Summary: The aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XW003 injection in Chinese adolescents with obesity
Study Start Date: Aug. 20
Study Type: INTERVENTIONAL
Condition:
Obese Adolescents
Obesity
Intervention:
DRUG: XW003 injection
Subcutaneous injection
DRUG: placebo with matching volume
Subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Disclaimer: Curated by HT Syndication....